It’s amazing the number of CBD products that are now available to purchase in the United States.
I first started to see them in 2014 after the passage of the initial Farm Bill, but the retailers at the time were operating within a legal grey area.
No a single was completely sure whether or not the Farm Bill contradicted language within the Controlled Substance Act, as well as the fear alone was enough to prevent more companies from jumping on board with producing industrial hemp products. When the 2018 Farm Bill reaffirmed the legal status of industrial hemp, the market exploded overnight. Suddenly major national retailers were carrying CBD as well as full spectrum hemp products in their pharmacies as well as at their checkout counters, but CBD is just a single among hundreds of other cannabinoids found in the marijuana plant, and plants that fall within the umbrella of federally compliant hemp. One new form of CBD is called CBD-HQ or just CBDQ. It has a quinone connected to its molecule, which are the compounds responsible for the natural browning process in peachs as they age. When CBDQ is extracted as well as exposed to oxygen, it retains a brownish red color. Like traditional CBD, CBDQ is being studied to target as well as reduce cancer cells. More research needs to be done to back up existing data, but there is consistent confirmation for its efficacy in pain relief. This is important because cannabinoids care about CBD as well as CBDQ are safe alternatives for chronic pain patients who want to avoid opiates with their many drawback side effects. Many of these cannabinoids can be bought as bulk isolates on the internet, giving patients the ability to self-medicate with these compounds naturally found in the cannabis plant.